Literature DB >> 23499963

Feasibility of circulating miRNA microarray analysis from archival plasma samples.

Maurizio Callari1, Paola Tiberio, Loris De Cecco, Elena Cavadini, Matteo Dugo, Chiara Ghimenti, Maria Grazia Daidone, Silvana Canevari, Valentina Appierto.   

Abstract

MicroRNAs have been found to be deregulated in several diseases and, due to their high stability in body fluids, represent promising noninvasively detectable biomarkers. However, numerous technical variables can affect accurate measurement of circulating miRNAs. Using a microarray-based method we assessed the: (i) adequate intra- and inter-array reproducibility of miRNA profiling; (ii) feasibility of using archival plasma samples stored for an extended period of time and available in limited amounts; (iii) good correlation between different batches; and (iv) time-dependent increase of background signals close to the chip expiration date.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23499963     DOI: 10.1016/j.ab.2013.03.002

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

Review 1.  Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.

Authors:  Chiranjib Chakraborty; Srijit Das
Journal:  Tumour Biol       Date:  2016-01-29

2.  Rapid and label-free fluorescence bioassay for microRNA based on exonuclease III-assisted cycle amplification.

Authors:  Ming Xiu Liu; Shuping Liang; Yafang Tang; Jianniao Tian; YanChun Zhao; Shulin Zhao
Journal:  RSC Adv       Date:  2018-04-30       Impact factor: 3.361

Review 3.  Challenges in using circulating miRNAs as cancer biomarkers.

Authors:  Paola Tiberio; Maurizio Callari; Valentina Angeloni; Maria Grazia Daidone; Valentina Appierto
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

4.  MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance.

Authors:  Dong Lan; Xin Zhang; Rongquan He; Ruixue Tang; Ping Li; Qiancheng He; Gang Chen
Journal:  Eur J Med Res       Date:  2015-04-23       Impact factor: 2.175

5.  Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.

Authors:  Valentina Doldi; Maurizio Callari; Elisa Giannoni; Francesca D'Aiuto; Massimo Maffezzini; Riccardo Valdagni; Paola Chiarugi; Paolo Gandellini; Nadia Zaffaroni
Journal:  Oncotarget       Date:  2015-10-13

6.  Circulating microRNAs correlate to clinical parameters in individuals with allergic and non-allergic asthma.

Authors:  Julie Weidner; Linda Ekerljung; Carina Malmhäll; Nicolae Miron; Madeleine Rådinger
Journal:  Respir Res       Date:  2020-05-07

7.  Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.

Authors:  Elena Landoni; Rosalba Miceli; Maurizio Callari; Paola Tiberio; Valentina Appierto; Valentina Angeloni; Luigi Mariani; Maria Grazia Daidone
Journal:  BMC Bioinformatics       Date:  2015-11-18       Impact factor: 3.169

Review 8.  MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.

Authors:  Manuele Gori; Mario Arciello; Clara Balsano
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

9.  Circulating MicroRNAs: Association with Lung Function in Asthma.

Authors:  Alvin T Kho; Sunita Sharma; Joshua S Davis; Joseph Spina; Dagnie Howard; Kevin McEnroy; Kip Moore; Jody Sylvia; Weiliang Qiu; Scott T Weiss; Kelan G Tantisira
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

10.  Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers.

Authors:  Ni Li; Jiangfang Lian; Sheng Zhao; Dawei Zheng; Xi Yang; Xiaoyan Huang; Xinbao Shi; Lebo Sun; Qingyun Zhou; Huoshun Shi; Guodong Xu; Enchill KoJo Incoom; Jianqing Zhou; Guofeng Shao
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.